Cir Cir. 2025;93(6):599-607. doi: 10.24875/CIRU.24000235.
ABSTRACT
OBJECTIVE: This study was conducted to investigate the levels of nuclear factor (erythroid derivative 2)-like 2 (NRF-2), kidney injury molecule 1 (KIM-1), and heme oxygenase-1 (HO-1) in pericardial fluid (PF) and systemic circulation of patients undergoing cardiac surgery.
METHODS: This study included 40 patients undergoing cardiac surgery and 40 healthy individuals. PF and venous blood samples were obtained from the patients and renal function tests, HO-1, KIM-1, NRF-2, antioxidant, and oxidative stress parameters were studied.
RESULTS: A statistically significant difference was found in the NRF-2, KIM-1, HO-1, total antioxidant status, total oxidant status, and oxidative stress index measurements in the plasma of the patient and control groups and in the PF of the patients (p < 0.01). Compared to the control group, NRF-2, KIM-1, and HO-1 were found to be lower in the patient’s plasma and PF. In the patient group, NRF-2, KIM-1, HO-1, and KIM-1 were higher in PF compared to plasma.
CONCLUSIONS: In the future, intrapericardial drug administration may improve cardiac function and prevent the adverse cardiorenal syndrome on the kidney.
PMID:41558054 | DOI:10.24875/CIRU.24000235
